Kolexia
Lepine Zoe Neurologie
Lepine Zoe
Neurologie
Centre Hospitalier de Pau
Pau, France
19 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Neuromyélite optique Sclérose en plaques Sclérose Neutropénie COVID-19 Troubles tardifs Effets secondaires indésirables des médicaments Tumeurs du poumon Maladies démyélinisantes auto-immunes du SNC

Collaborateurs

Voir plus
Biotti Damien
Biotti Damien
Hôpital Purpan, Toulouse, France
Ciron Jonathan
Ciron Jonathan
Hôpital Purpan, Toulouse, France
Rigal Julien
Rigal Julien
Hôpital Saint Pierre, Saint-Pierre, France
Viala Frederique
Viala Frederique
Cabinet libéral, Toulouse, France

Industries

Voir plus
Novartis
2 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
2 grams versus 1 gram rituximab as maintenance schedule in multiple sclerosis, neuromyelitis optica spectrum disorders and related diseases: What B-cell repopulation data tell us.
Multiple sclerosis and related disorders   10 février 2023
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors.
Neurology(R) neuroimmunology & neuroinflammation   29 novembre 2022
Late-onset neutropenia after anti-CD20 therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG antibody-associated disease: A prospective study.
Revue neurologique   24 septembre 2021
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders
Multiple sclerosis (Houndmills, Basingstoke, England) Congress 2020   07 décembre 2020
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders.
European journal of neurology   27 novembre 2020
Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-series.
Multiple sclerosis and related disorders   03 septembre 2020
Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases.
Multiple sclerosis and related disorders   22 février 2020
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}